Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.

The 30-30-30 diet has been gaining attention in the wellness world for its simple, structured approach to weight loss and metabolic health,” explains Serena Poon, C.N., CHC, ...

Researchers linked higher weight loss after initiating antiobesity meds to lower risk for revision of hip and knee replacement.

The researchers found that the 5-year risks for revision among 3691 participants was 5.6% for patients in the weight gain or stable weight group compared with 3.9% in patient with greater than 10% ...